Clinical trial
Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's…
NCT00239564 · Impax Laboratories, LLC, Industry · Completed
Key facts
| NCT number | NCT00239564 |
|---|---|
| Title | Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's Disease |
| Official title | An Open-Label Study to Assess the Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's Disease |
| Lead sponsor | Impax Laboratories, LLC, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Idiopathic Parkinson's Disease |
| Intervention type | Drug |
| Interventions | IPX054 100 mg, IPX054 150 mg, IPX054 200 mg, IPX054 250 mg, IPX054 300 mg |
| Enrollment | 12 |
| Start date | Oct 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Oct 17, 2005 |
| Last update posted | Oct 29, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: